Evidence map›Paper›PMID 28514968›Full record

ArticleMalaria journal2017

Further evaluation of the NWF filter for the purification of Plasmodium vivax-infected erythrocytes.

Jiangyan Li, Zhiyong Tao, Qian Li, Awtum Brashear, Ying Wang, Hui Xia, Qiang Fang, Liwang Cui

Open access · goldAbstract read
In one paragraph

Article in Malaria journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 16 citations in OpenAlex.

  1. Accessing invasion-competentScience advances · 2026
    Article
  2. Article
  3. Low-volumeMicrobial genomics · 2025
    Article
  4. Article
  5. Article
  6. A Drug Repurposing Approach Reveals Targetable Epigenetic Pathways inbioRxiv : the preprint server for biology · 2024
    Article
  7. Article
  8. Molecular Surveillance andFrontiers in cellular and infection microbiology · 2021
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. NewFrontiers in microbiology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Jiangyan LiDepartment of Microbiology and Parasitology, Bengbu Medical College, Bengbu, China.
Zhiyong TaoDepartment of Microbiology and Parasitology, Bengbu Medical College, Bengbu, China.
Qian LiDepartment of Microbiology and Parasitology, Bengbu Medical College, Bengbu, China.
Awtum BrashearDepartment of Entomology, Pennsylvania State University, 501 ASI Building, University Park, PA, USA.
Ying WangInstitute of Tropical Medicine, Third Military Medical University, Chongqing, China.
Hui XiaDepartment of Microbiology and Parasitology, Bengbu Medical College, Bengbu, China.
Qiang FangDepartment of Microbiology and Parasitology, Bengbu Medical College, Bengbu, China. fq333@sohu.com.
Liwang CuiDepartment of Entomology, Pennsylvania State University, 501 ASI Building, University Park, PA, USA. luc2@psu.edu.
Bengbu Medical College · CNPennsylvania State University · USArmy Medical University · CN

Funding

Southeast Asia Malaria Research CenterU19AI089672 · NIAID · UNIVERSITY OF SOUTH FLORIDA · PI CUI, LIWANG · 2010 to 2023
$28.9M
Penn State Biomedical Big Data to Knowledge (B2D2K) Training ProgramT32LM012415 · NLM · PENNSYLVANIA STATE UNIVERSITY, THE · PI BROACH, JAMES R., HONAVAR, VASANT G. · 2016 to 2020
$1.2M
NIAID NIH HHS U19 AI089672NLM NIH HHS T32 LM012415
6 · The paper itself

Abstract

backgroundIsolation of Plasmodium-infected red blood cells (iRBCs) from clinical blood samples is often required for experiments, such as ex vivo drug assays, in vitro invasion assays and genome sequencing. Current methods for removing white blood cells (WBCs) from malaria-infected blood are time-consuming or costly. A prototype non-woven fabric (NWF) filter was developed for the purification of iRBCs, which showed great efficiency for removing WBCs in a pilot study. Previous work was performed with prototype filters optimized for processing 5-10 mL of blood. With the commercialization of the filters, this study aims to evaluate the efficiency and suitability of the commercial NWF filter for the purification of Plasmodium vivax-infected RBCs in smaller volumes of blood and to compare its performance with that of Plasmodipur

methodsForty-three clinical P. vivax blood samples taken from symptomatic patients attending malaria clinics at the China-Myanmar border were processed using the NWF filters in a nearby field laboratory. The numbers of WBCs and iRBCs and morphology of P. vivax parasites in the blood samples before and after NWF filtration were compared. The viability of P. vivax parasites after filtration from 27 blood samples was examined by in vitro short-term culture. In addition, the effectiveness of the NWF filter for removing WBCs was compared with that of the Plasmodipur

resultsFiltration of 1-2 mL of P. vivax-infected blood with the NWF filter removed 99.68% WBCs. The densities of total iRBCs, ring and trophozoite stages before and after filtration were not significantly different (P > 0.05). However, the recovery rates of schizont- and gametocyte-infected RBCs, which were minor parasite stages in the clinical samples, were relatively low. After filtration, the P. vivax parasites did not show apparent morphological changes. Culture of 27 P. vivax-infected blood samples after filtration showed that parasites successfully matured into the schizont stage. The WBC removal rates and iRBC recovery rates were not significantly different between the NWF and Plasmodipur

conclusionsWhen tested with 1-2 mL of P. vivax-infected blood, the NWF filter could effectively remove WBCs and the recovery rates for ring- and trophozoite-iRBCs were high. P. vivax parasites after filtration could be successfully cultured in vitro to reach maturity. The performance of the NWF and Plasmodipur

Indexed as

BloodCell SeparationErythrocytesFiltrationHumansLeukocytesMalaria, VivaxPilot ProjectsPlasmodium vivaxTextilesField evaluationFilterInfected red blood cellPlasmodium vivaxPurification

Identifiers

PMID28514968
PMCPMC5436455
OpenAlexW2614692714

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.